Todd Foley
6 additional roles and seats, 7 additional attributed investments
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days.
Roles
- MPM Bioimpact Managing DirectorNov 1, 2015 to present · “Schedule A: FOLEY, TODD, THOMAS, MANAGING DIRECTOR, since 11/2015, ownership NA, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Crossbow Therapeutics, Inc. | board only | MPM Bioimpact | strongly supported · board | Sep 30, 2025 | Inference sec.gov |
| Aktis Oncology, Inc. | board only | MPM Bioimpact | strongly supported · board | Oct 2, 2024 | Inference sec.gov |
| Firefly Bio, Inc. | board only | MPM Bioimpact | strongly supported · board | Mar 26, 2024 | Inference sec.gov |
Board seats and vehicles
- Crossbow Therapeutics, Inc. Director Sep 30, 2025 Inference
- Aktis Oncology, Inc. Director Oct 2, 2024 Inference
- Firefly Bio, Inc. Director Mar 26, 2024 Inference
- MPM Bioventures 2018, L.P. Executive Officer/Promoter Feb 22, 2018
- MPM Bioventures 2018 (b), L.P. Executive Officer/Promoter Feb 23, 2018
- MPM Bio 2014 Nvs Strategic Fund, L.P. Director May 29, 2014
Timeline
- Sep 30, 2025Board seat at Crossbow Therapeutics, Inc. (MPM Bioimpact)
- Oct 2, 2024Board seat at Aktis Oncology, Inc. (MPM Bioimpact)
- Mar 26, 2024Board seat at Firefly Bio, Inc. (MPM Bioimpact)
- Nov 1, 2015Joined MPM Bioimpact as Managing Director
Relationships across DFX
on 1 other DFX graph
Todd Foley is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…